Abstract
Although anecdotal reports suggest that cannabis may be used to alleviate symptoms of depression, the psychotropic effects and abuse liability of this drug prevent its therapeutic application. The active constituent of cannabis, Δ 9 -tetrahydrocannabinol, acts by binding to brain CB 1 cannabinoid receptors, but an alternative approach might be to develop agents that amplify the actions of endogenous cannabinoids by blocking their deactivation. Here, we show that URB597, a selective inhibitor of the enzyme fatty-acid amide hydrolase, which catalyzes the intracellular hydrolysis of the endocannabinoid anandamide, exerts potent antidepressant-like effects in the mouse tail-suspension test and the rat forced-swim test. Moreover, URB597 increases firing activity of serotonergic neurons in the dorsal raphe nucleus and noradrenergic neurons in the nucleus locus ceruleus. These actions are prevented by the CB 1 antagonist rimonabant, are accompanied by increased brain anandamide levels, and are maintained upon repeated URB597 administration. Unlike direct CB 1 agonists, URB597 does not exert rewarding effects in the conditioned place preference test or produce generalization to the discriminative effects of Δ 9 -tetrahydrocannabinol in rats. The findings support a role for anandamide in mood regulation and point to fatty-acid amide hydrolase as a previously uncharacterized target for antidepressant drugs.
Bibliography
Gobbi, G., Bambico, F. R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., Tontini, A., Tarzia, G., Mor, M., Trezza, V., Goldberg, S. R., Cuomo, V., & Piomelli, D. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences, 102(51), 18620â18625.
Authors
17
- G. Gobbi (first)
- F. R. Bambico (additional)
- R. Mangieri (additional)
- M. Bortolato (additional)
- P. Campolongo (additional)
- M. Solinas (additional)
- T. Cassano (additional)
- M. G. Morgese (additional)
- G. Debonnel (additional)
- A. Duranti (additional)
- A. Tontini (additional)
- G. Tarzia (additional)
- M. Mor (additional)
- V. Trezza (additional)
- S. R. Goldberg (additional)
- V. Cuomo (additional)
- D. Piomelli (additional)
References
39
Referenced
570
- (1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (Am. Psychiatr. Assoc. Washington DC).
10.1001/archpsyc.58.4.322
10.1016/0925-4927(96)02817-X
10.1097/00001756-200306110-00009
10.1016/S0896-6273(02)00653-0
10.1093/brain/awg143
10.1192/bjp.178.41.s107
10.1046/j.1360-0443.2003.00437.x
10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C
10.1097/00126334-200401010-00005
10.1177/104990910402100206
10.1016/j.jpainsymman.2004.07.011
- Ware, M. A., Adams, H. & Guy, G. W. (2005) Int. J. Clin. Pract. 59, 291-295.15857325 / Int. J. Clin. Pract. (2005)
10.1152/physrev.00004.2003
10.1038/nrn1247
10.1038/nm803
10.1021/jm021119g
10.1021/jm031140x
10.1124/jpet.104.078980
10.1124/jpet.102.047928
10.1007/BF00428203
10.1038/266730a0
- Roux S. Froger C. Porsolt R. D. Valverde O. & Maldonado R. (2004) in Current Protocols in Neuroscience (Wiley New York).
10.1046/j.0953-816x.2001.01583.x
10.1016/S0893-133X(01)00306-2
10.1038/28393
10.1016/j.lfs.2005.05.012
10.1007/s002130051156
10.1016/j.pbb.2005.01.032
10.1097/00004714-200302000-00011
10.1016/S0306-4522(00)00060-9
10.1016/j.peptides.2005.03.032
10.1038/nature03658
10.1038/sj.npp.1300535
10.1097/00001756-199701200-00023
10.1097/01.fbp.0000135704.56422.40
10.1016/j.neuropharm.2004.01.003
10.1111/j.1460-9568.2005.03916.x
10.1210/en.2004-0638
Dates
Type | When |
---|---|
Created | 19 years, 8 months ago (Dec. 13, 2005, 9:38 p.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 10:23 a.m.) |
Indexed | 22 minutes ago (Aug. 30, 2025, 3:14 a.m.) |
Issued | 19 years, 8 months ago (Dec. 13, 2005) |
Published | 19 years, 8 months ago (Dec. 13, 2005) |
Published Online | 19 years, 8 months ago (Dec. 13, 2005) |
Published Print | 19 years, 8 months ago (Dec. 20, 2005) |
@article{Gobbi_2005, title={Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis}, volume={102}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0509591102}, DOI={10.1073/pnas.0509591102}, number={51}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Gobbi, G. and Bambico, F. R. and Mangieri, R. and Bortolato, M. and Campolongo, P. and Solinas, M. and Cassano, T. and Morgese, M. G. and Debonnel, G. and Duranti, A. and Tontini, A. and Tarzia, G. and Mor, M. and Trezza, V. and Goldberg, S. R. and Cuomo, V. and Piomelli, D.}, year={2005}, month=dec, pages={18620–18625} }